Literature DB >> 26715401

Psoriasis and Sleep Apnea: A Danish Nationwide Cohort Study.

Alexander Egeberg1,2, Usman Khalid1, Gunnar Hilmar Gislason1, Lotus Mallbris3, Lone Skov2, Peter Riis Hansen1.   

Abstract

STUDY
OBJECTIVES: Psoriasis and sleep apnea are associated with significant morbidity and mortality. Although both diseases have been linked with systemic inflammation, studies on their potential bidirectional association are lacking. We investigate the potential association between psoriasis and sleep apnea.
METHODS: All Danish citizens age 18 y or older between January 1, 1997 and December 31, 2011 (n = 5,522,190) were linked at individual level in nationwide registries. Incidence rates (IRs) per 10,000 person-years were calculated and incidence rate ratios (IRRs) adjusted for age, sex, socioeconomic status, smoking history, alcohol abuse, medication, and comorbidity were estimated by Poisson regression.
RESULTS: There were 53,290, 6,885, 6,348, and 39,908 incident cases of mild psoriasis, severe psoriasis, psoriatic arthritis, and sleep apnea, respectively. IRRs (95% confidence interval) for sleep apnea were 1.30 (1.17-1.44), 1.65 (1.23-2.22), and 1.75 (1.35-2.26) in subjects with mild and severe psoriasis, and psoriatic arthritis, and IRRs for mild and severe psoriasis, and psoriatic arthritis in sleep apnea without continuous positive airway pressure (CPAP) therapy were 1.62 (1.41-1.86), 2.04 (1.47-2.82), and 1.94 (1.34-2.79), respectively. In patients with sleep apnea and CPAP therapy (i.e., severe sleep apnea) the IRRs were 1.82 (1.43-2.33), 3.27 (2.03-5.27), and 5.59 (3.74-8.37), respectively.
CONCLUSIONS: Psoriasis was associated with increased risk of sleep apnea, and sleep apnea was associated with increased risk of psoriasis. The clinical significance of this bidirectional relationship warrants further study.
© 2016 American Academy of Sleep Medicine.

Entities:  

Keywords:  epidemiology; inflammation; psoriasis; risk; sleep apnea

Mesh:

Year:  2016        PMID: 26715401      PMCID: PMC4865552          DOI: 10.5664/jcsm.5790

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  47 in total

1.  Risk of thromboembolism and fatal stroke in patients with psoriasis and nonvalvular atrial fibrillation: a Danish nationwide cohort study.

Authors:  O Ahlehoff; G Gislason; M Lamberts; F Folke; J Lindhardsen; C T Larsen; C Torp-Pedersen; P R Hansen
Journal:  J Intern Med       Date:  2014-06-13       Impact factor: 8.989

2.  Improved Sleep Efficiency after Anti-Tumor Necrosis Factor α Therapy in Rheumatoid Arthritis Patients.

Authors:  Regina M Taylor-Gjevre; John A Gjevre; Bindu V Nair; Robert P Skomro; Hyun J Lim
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-10       Impact factor: 5.346

3.  Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome.

Authors:  Silke Ryan; Cormac T Taylor; Walter T McNicholas
Journal:  Circulation       Date:  2005-10-25       Impact factor: 29.690

4.  Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients.

Authors:  Giovanna E Carpagnano; Sergei A Kharitonov; Onofrio Resta; Maria P Foschino-Barbaro; Enzo Gramiccioni; Peter J Barnes
Journal:  Chest       Date:  2002-10       Impact factor: 9.410

5.  Trends in incidence of adult-onset psoriasis over three decades: a population-based study.

Authors:  Murat Icen; Cynthia S Crowson; Marian T McEvoy; Frank J Dann; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  J Am Acad Dermatol       Date:  2009-03       Impact factor: 11.527

Review 6.  Transcriptional responses to intermittent hypoxia.

Authors:  Jayasri Nanduri; Guoxiang Yuan; Ganesh K Kumar; Gregg L Semenza; Nanduri R Prabhakar
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

7.  Effect of adalimumab on sleep parameters in patients with psoriasis and obstructive sleep apnea: a randomized controlled trial.

Authors:  Catherine Maari; Chantal Bolduc; Simon Nigen; Philippe Marchessault; Robert Bissonnette
Journal:  J Dermatolog Treat       Date:  2012-09-19       Impact factor: 3.359

Review 8.  Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis.

Authors:  April W Armstrong; Caitlin T Harskamp; Ehrin J Armstrong
Journal:  JAMA Dermatol       Date:  2013-01       Impact factor: 10.282

9.  Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011.

Authors:  April W Armstrong; Clayton Schupp; Bruce Bebo
Journal:  Dermatology       Date:  2012-10-26       Impact factor: 5.366

10.  Psoriasis severity and the prevalence of major medical comorbidity: a population-based study.

Authors:  Howa Yeung; Junko Takeshita; Nehal N Mehta; Stephen E Kimmel; Alexis Ogdie; David J Margolis; Daniel B Shin; Rosemary Attor; Andrea B Troxel; Joel M Gelfand
Journal:  JAMA Dermatol       Date:  2013-10       Impact factor: 10.282

View more
  11 in total

1.  Bidirectional Relationship between Obstructive Sleep Apnea (OSA) and Psoriasis: Implications for OSA Therapies?

Authors:  Madhulika A Gupta; Fiona C Simpson; Aditya K Gupta
Journal:  J Clin Sleep Med       Date:  2016-09-15       Impact factor: 4.062

2.  Effect of Biological Therapy on the Risk of Sleep Apnea in Patients with Psoriasis.

Authors:  Alexander Egeberg; Lone Skov
Journal:  J Clin Sleep Med       Date:  2016-09-15       Impact factor: 4.062

3.  Psoriasis is associated with risk of obstructive sleep apnea independently from metabolic parameters and other comorbidities: a large hospital-based case-control study.

Authors:  Evangelia Papadavid; Maria Dalamaga; Katerina Vlami; Dimitra Koumaki; Sotirios Gyftopoulos; Gerasimos Socrates Christodoulatos; Spyridon Papiris; Dimitrios Rigopoulos
Journal:  Sleep Breath       Date:  2017-05-08       Impact factor: 2.816

4.  Multimorbidity and overall comorbidity of sleep apnoea: a Finnish nationwide study.

Authors:  Marja Palomäki; Tarja Saaresranta; Ulla Anttalainen; Markku Partinen; Jaana Keto; Miika Linna
Journal:  ERJ Open Res       Date:  2022-06-06

Review 5.  Sleep Disorders and Psoriasis: An Update.

Authors:  Bruno Halioua; Clara Chelli; Laurent Misery; Jonathan Taieb; Charles Taieb
Journal:  Acta Derm Venereol       Date:  2022-04-27       Impact factor: 3.875

Review 6.  Measurement, Classification and Evaluation of Sleep Disturbance in Psoriasis: A Systematic Review.

Authors:  Alasdair L Henry; Simon D Kyle; Sahil Bhandari; Anna Chisholm; Christopher E M Griffiths; Christine Bundy
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

Review 7.  Sleep Problems in Chronic Inflammatory Diseases: Prevalence, Treatment, and New Perspectives: A Narrative Review.

Authors:  Marta Ditmer; Agata Gabryelska; Szymon Turkiewicz; Piotr Białasiewicz; Ewa Małecka-Wojciesko; Marcin Sochal
Journal:  J Clin Med       Date:  2021-12-23       Impact factor: 4.241

8.  Chronic Inflammation as the Underlying Mechanism of the Development of Lung Diseases in Psoriasis: A Systematic Review.

Authors:  Mateusz Mleczko; Agnieszka Gerkowicz; Dorota Krasowska
Journal:  Int J Mol Sci       Date:  2022-02-04       Impact factor: 5.923

Review 9.  Psoriasis and Respiratory Comorbidities: The Added Value of Fraction of Exhaled Nitric Oxide as a New Method to Detect, Evaluate, and Monitor Psoriatic Systemic Involvement and Therapeutic Efficacy.

Authors:  Pierachille Santus; Maurizio Rizzi; Dejan Radovanovic; Andrea Airoldi; Andrea Cristiano; Rosalynn Conic; Stephen Petrou; Paolo Daniele Maria Pigatto; Nicola Bragazzi; Delia Colombo; Mohamad Goldust; Giovanni Damiani
Journal:  Biomed Res Int       Date:  2018-09-23       Impact factor: 3.411

Review 10.  The Risk of Systemic Diseases in Those with Psoriasis and Psoriatic Arthritis: From Mechanisms to Clinic.

Authors:  Yu Ri Woo; Chul Jong Park; Hoon Kang; Jung Eun Kim
Journal:  Int J Mol Sci       Date:  2020-09-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.